ACIP endorses FluMist for 2-, 3-, and 4-year-olds

Influenza, General

Oct 25, 2007 (CIDRAP News) – A federal advisory committee yesterday endorsed FluMist, the nasal-spray form of seasonal influenza vaccine, as a good option for children aged 2 through 4 years.

The Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP), in recommending FluMist for the age-group, said the needle-free vaccine should be given only to healthy children, according to an Associated Press (AP) report yesterday. The committee said children who have a history of asthma should receive a standard flu shot. The CDC normally adopts ACIP recommendations.

The ACIP's vote came a little more than a month after the Food and Drug Administration (FDA) approved FluMist for children in the 2- to 4-year-old group. The vaccine's previous FDA indication and ACIP recommendation was only for healthy people between the ages of 5 and 49. FluMist contains a weakened form of live virus and is made by MedImmune, based in Gaithersburg, Md., now part of AstraZeneca.

The committee didn't recommend FluMist over regular flu shots, but simply designated it as an option for small children who fear injections, the AP reported. Flu shots in general are recommended for children aged 6 months to 5 years, among several other groups at risk for flu complications.

The committee also recommended that a government program that funds vaccines for certain groups of children extend its coverage for FluMist to include the younger children, meaning more than 5 million children will be eligible to receive the nasal spray vaccine, the AP reported. The program covers children with Medicaid coverage, Native American and Alaska native groups, and some children whose medical insurance doesn't cover flu shots.

MedImmune has produced about 4.5 million doses of FluMist for the 2007-08 flu season, a company official told the AP. Last year the company made about 3 million doses.

With FluMist, three flu vaccines are now available in the United States for children younger than 5 years. The others are Fluzone, made by Sanofi Pasteur Inc., Swiftwater, Pa., approved for anyone older than 6 months, and Fluvirin, made by Novartis Vaccines and Diagnostics, Liverpool, England, licensed for ages 4 and up.

See also:

Sep 20 CIDRAP News story "FDA approves FluMist for 2- to 4-year-old children"

This week's top reads

  1. Vietnam reports H5N1 avian flu case with encephalitis

    Tests on respiratory samples were negative, but results were positive for the cerebrospinal fluid sample.

    Lisa Schnirring
    ICU monitors

  2. Studies detail high rates of long COVID among healthcare, dental workers

    The most common symptom reported by healthcare workers was fatigue.

    Stephanie Soucheray
    health worker in mask

  3. Top virologists urge world leaders to act on rising avian flu threat

    Global Virus Network scientists highlight the need for robust surveillance, enhanced biosecurity, and readiness for potential human-to-human viral transmission.

    Mary Van Beusekom

  4. CIDRAP launches Vaccine Integrity Project to help safeguard US vaccine use

    The steering committee will make recommendations on how non-governmental groups can help ensure that vaccine use is evidence-based.

    Mary Van Beusekom
    MMR vaccine vial on table

  5. US measles cases climb higher, approach 900

    Thirty states have cases, and 83% of infections are part of outbreaks, the largest centered  in West Texas.

    Lisa Schnirring
    young boy with measles

  6. Tick-borne meat allergy may be related to urbanization in mid-Atlantic US

    The study identified open-space development and low population density as risk factors for Alpha-gal syndrome. 

    Mary Van Beusekom
    Lone star tick

  7. USDA withdraws proposal to reduce Salmonella in poultry

    The Biden-era rule would have prevented the sale of raw chicken or turkey with certain levels or strains of Salmonella.

    Chris Dall
    Raw poultry in processing plant

  8. New agreement geared toward universal avian flu vaccine

    The mRNA vaccine targets all major clades of the H5 avian flu subtype.

    Stephanie Soucheray

  9. Quick takes: Mpox outbreak in Malawi, more H5N1 in Idaho and California dairy cows

    The cases in Malawi bring the number of African countries affected by mpox to 23.

    Lisa Schnirring

  10. Measles cases in Europe, the Americas skyrocket

    Almost 90% of the European cases were reported in Romania.

    Stephanie Soucheray
    measles vax

Our underwriters